By encapsulating human liver cells, researchers at the Massachusetts Institute of Technology (MIT) have been able to make an artificial liver that can evade immune detection for a week after it is implanted into mice. The work could greatly improve preclinical metabolic and toxicity testing of drug candidates in the near term – and could one day improve human liver transplants, as well.